Gladstone NOW: The Campaign Join Us on the Journey ✕
1441 - 1455 of 1470 Results Clear All
SAN FRANCISCO—March 3, 2010—With obesity and obesity-related diseases epidemic in the developed world, a clear understanding of how metabolism is regulated is crucial. One of the key metabolic pathways involves the oxidation of fat.
SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.
Awards Alzheimer’s Disease
WASHINGTON—February 10, 2010—Robert W. Mahley, MD, PhD, president of The J. David Gladstone Institutes, will receive Research!America's 2010 Builders of Science Award.
Awards
SAN FRANCISCO, CA—February 8, 2010—The J. David Gladstone Institutes has announced the completion of its first fundraising campaign. The independent biomedical research organization, located at Mission Bay, said it had exceeded its goal of $35 million, despite tough economic times.
SAN FRANCISCO, CA—February 3, 2010—Although obesity is a risk factor for diabetes and coronary heart disease worldwide, only some obese individuals go on to develop these metabolic complications, while others are relatively protected.
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) was awarded the 2010 March of Dimes Prize in Developmental Biology.
SAN FRANCISCO, CA—January 13, 2010—Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.
Greene Lab HIV/AIDS
SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?
Alzheimer’s Disease Gan Lab Huang Lab
SAN FRANCISCO, CA—November 9, 2009—The Gladstone Institutes today announced that it has hired Bruce Spaulding, who recently retired as UCSF'S senior vice chancellor of advancement and planning as its new chief of strategic planning, effective December 14th.
SAN FRANCISCO, CA—November 1, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine t
SAN FRANCISCO, CA—October 28, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) will receive $10 million over the next 6 years to find the genetic causes of congenital heart disease.
SAN FRANCISCO, CA—October 28, 2009—For the fifth year in a row, The J. David Gladstone Institutes has placed among the top 10 among the Best Places to Work in Academia.
SAN FRANCISCO, CA—October 23, 2009—The J. David Gladstone Institutes today announced that Robert Sanders “Sandy” Williams, MD, has been appointed the new president of the Institutes. Dr.
SAN FRANCISCO, CA—October 13, 2009—The National Institutes of Health (NIH) has awarded a “Grand Opportunity” grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease(GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell techno
Huntington’s Disease
